Tumor Mutational Burden Predicts Progression-Free Survival and Local-Regional Control in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Durvalumab

被引：0
|
作者：
Shaverdian, N. [1 ]
Shepherd, A. F. [1 ]
Offin, M. [2 ]
Gelblum, D. [1 ]
Wu, A. J. [1 ]
Simone, C. B., II [3 ]
Schoenfeld, A. J. [2 ]
Jones, D. [4 ]
Rimner, A. [1 ]
Chaft, J. [4 ]
Riaz, N. [1 ]
Gomez, D. R. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] New York Proton Ctr, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2873
引用
收藏
页码：E390 / E391
页数：2
相关论文
共 50 条
  • [1] Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab
    Lebow, Emily S.
    Shepherd, Annemarie
    Eichholz, Jordan E.
    Offin, Michael
    Gelblum, Daphna Y.
    Wu, Abraham J.
    Simone, Charles B.
    Schoenfeld, Adam J.
    Jones, David R.
    Rimner, Andreas
    Chaft, Jamie E.
    Riaz, Nadeem
    Gomez, Daniel R.
    Shaverdian, Narek
    [J]. JAMA NETWORK OPEN, 2023, 6 (01) : E2249591
  • [2] PROGNOSTIC MODEL FOR PROGRESSION FREE SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH CONCURRENT CHEMORADIATION
    Uyterlinde, W.
    Vincent, A. D.
    Belderbos, J.
    Korse, T.
    Baas, P.
    van den Heuvel, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 392 - 393
  • [3] Al Serial Image Prediction of Progression-Free Survival (PFS) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients Treated with Chemoradiation (CRT) and Durvalumab Consolidation
    Veeraraghavan, H.
    Jiang, J.
    Jee, J.
    Lebow, E. S.
    Deasy, J. O.
    Rimner, A.
    Shaverdian, N.
    Yu, H.
    Gomez, D. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E68 - E68
  • [4] Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab
    Gao, Robert W.
    Day, Courtney N.
    Yu, Nathan Y.
    Bush, Aaron
    Amundson, Adam C.
    Prodduturvar, Pranitha
    Majeed, Umair
    Butts, Emily
    Oliver, Thomas
    Schwecke, Anna J.
    Moffett, Jenesse N.
    Routman, David M.
    Breen, William G.
    Potter, Ashley L.
    Rivera-Concepcion, Joel
    Hoppe, Bradford S.
    Schild, Steven E.
    Sio, Terence T.
    Lou, Yanyan
    Ernani, Vinicius
    Ko, Stephen
    Olivier, Kenneth R.
    Merrell, Kenneth W.
    Garces, Yolanda, I
    Manochakian, Rami
    Harmsen, William S.
    Leventakos, Konstantinos
    Owen, Dawn
    [J]. LUNG CANCER, 2022, 170 : 58 - 64
  • [5] Prognostic Model for Progression-Free Survival in Patients With Stage III Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
    Peulen, H. M.
    Uyterlinde, W.
    Belderbos, J.
    Vincent, A.
    Korse, C.
    van Diessen, J.
    Sonke, J. J.
    van den Heuvel, M. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S657 - S657
  • [6] Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab
    Diamond, Brett H.
    Belani, Neel
    Masel, Rebecca
    DeCarli, Kathryn
    DiPetrillo, Thomas
    Hepel, Jaroslaw T.
    Azzoli, Christopher G.
    Khurshid, Humera
    Abbas, Abbas
    Koffer, Paul P.
    [J]. ADVANCES IN RADIATION ONCOLOGY, 2023, 8 (02)
  • [7] Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer
    Hassanzadeh, Comron
    Sita, Timothy
    Savoor, Rohan
    Samson, Pamela P.
    Bradley, Jeffrey
    Gentile, Michelle
    Roach, Michael
    Mohindra, Nisha
    Waqar, Saiama
    Kruser, Timothy J.
    Robinson, Clifford
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 6690 - 6700
  • [8] Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
    Yamamoto, Takaya
    Tsukita, Yoko
    Katagiri, Yu
    Matsushita, Haruo
    Umezawa, Rei
    Ishikawa, Yojiro
    Takahashi, Noriyoshi
    Suzuki, Yu
    Takeda, Kazuya
    Miyauchi, Eisaku
    Saito, Ryota
    Katsuta, Yoshiyuki
    Kadoya, Noriyuki
    Jingu, Keiichi
    [J]. BMC CANCER, 2022, 22 (01)
  • [9] Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
    Takaya Yamamoto
    Yoko Tsukita
    Yu Katagiri
    Haruo Matsushita
    Rei Umezawa
    Yojiro Ishikawa
    Noriyoshi Takahashi
    Yu Suzuki
    Kazuya Takeda
    Eisaku Miyauchi
    Ryota Saito
    Yoshiyuki Katsuta
    Noriyuki Kadoya
    Keiichi Jingu
    [J]. BMC Cancer, 22
  • [10] Impact of tumor mutational burden on overall survival in patients with non-small cell lung cancer treated with immunotherapy
    Awad, Mark
    Mahadevan, Navin
    Polio, Andrew
    Vokes, Natalie
    Aguilar, Elizabeth
    Ricciuti, Biagio
    Lamberti, Giuseppe
    Recondo, Gonzalo
    Leonardi, Giulia
    Adeni, Anika
    Janne, Pasi
    Van Allen, Eliezer
    Albayrak, Adem
    Umeton, Renato
    Sholl, Lynette
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345